🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and effectiveness of bo...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00833560
Treatments Being Tested
This phase II trial studies the side effects and how well lower doses of bo...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02082405
This is a randomised, multicentre, controlled, open-label, Phase III global...
Status
Recruiting
Location
Research Site
Start Date
2026-06-26
Trial ID
NCT07764978
Treatments Being Tested
The purpose of this study is to look at whether bortezomib, mycophenolate o...
Status
Completed
Location
Northwestern University
Start Date
2016-03
Trial ID
NCT02370693
Treatments Being Tested
This randomized phase III trial compares how well combination chemotherapy ...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2014-10-04
Trial ID
NCT02112916
Treatments Being Tested
Dysferlin is a protein with an important role in the repair of muscle surfa...
Status
Terminated
Location
Neuromuskuläres Zentrum, Universitätsspital Basel
Start Date
2012-12
Trial ID
NCT01863004
Treatments Being Tested
This phase II trial studies how well ibrutinib with or without bortezomib a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-03-15
Trial ID
NCT03130348
Treatments Being Tested
Multiple myeloma (MM) is a malignant proliferative plasma cell disease, whi...
Status
Recruiting
Location
Qilu hospital of Shandong university
Start Date
2023-11-16
Trial ID
NCT06039735
Treatments Being Tested
The purpose of this study test the hypothesis that the combination of simva...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01332617
Treatments Being Tested
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2009-01
Trial ID
NCT00851552